COMMUNIQUÉS West-GlobeNewswire

-
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
01/02/2024 -
Pressure BioSciences Upcoming Investor Call to Discuss Recent Acquisition of Uncle Buds
01/02/2024 -
Renowned Actor and Artist Ice-T Works Alongside the International Myeloma Foundation to Raise Awareness of Multiple Myeloma in the African American Community During Black History Month
01/02/2024 -
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the Virtual Investor New to the Street Event
01/02/2024 -
Renexxion to Present at the Oppenheimer 34ᵗʰ Annual Healthcare Life Sciences Conference
01/02/2024 -
Teladoc Health to Announce Fourth Quarter 2023 Financial Results
01/02/2024 -
CytoDyn Announces Submission of Clinical Protocol to FDA and Initiation of Pre-Clinical Study in Glioblastoma
01/02/2024 -
SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference
01/02/2024 -
Enzo Biochem Reports Results of its Annual Meeting of Shareholders and Officer Appointments
01/02/2024 -
SeaStar Medical Granted Canadian Patent with Broad Claims Covering the Selective Cytopheretic Device Technology
01/02/2024 -
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
01/02/2024 -
Clearmind Medicine Announces Exclusive, Long-Term Licensing Agreement with Leading Israeli Research Center
01/02/2024 -
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
01/02/2024 -
Ardelyx to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
01/02/2024 -
Immuneering Announces Participation in February Investor Conferences
01/02/2024 -
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
01/02/2024 -
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
01/02/2024 -
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
01/02/2024 -
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
01/02/2024
Pages